First instrument-free method to detect multiple pathogens on site Our technology combines CRISPR-based sequence recognition with cell-free protein synthesis to deliver highly selective results directly at the point of care. The method is currently at proof of concept stage, with experimental validation of the core biological mechanisms.Norwegian Diagnostics develops a new molecular diagnostic method designed